Search results
Results from the WOW.Com Content Network
Endo Pharmaceuticals at various times was a significant funder of the American Pain Foundation, which has been accused of producing misleading and biased materials relating to opiod prescribing. [ 52 ] [ 53 ] APF shut down in 2012 after the United States Senate Committee on Finance began an investigation into the relationships between narcotic ...
NEW YORK (Reuters) -Bankrupt drugmaker Endo International will pay up to $465 million to settle the federal government's law enforcement, tax, and healthcare cost claims, the U.S. Department of ...
The 10-second takeaway For the quarter ended March 31 (Q1), Endo Pharmaceuticals Holdings missed slightly on revenues and met. Endo Pharmaceuticals Holdings (NAS: ENDP) reported earnings on May 1 ...
Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less ...
Margins matter. The more Endo Pharmaceuticals (NAS: ENDP) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to ...
From a former name: This is a redirect from a former name or working title of the target topic to the new name that resulted from a name change.
Endo Pharmaceuticals agreed to pay $171.9 million to resolve civil liability under the False Claims Act for its off-label promotion of Lidoderm. The government charged that, between 2002 and 2006, Endo misbranded Lidoderm and introduced it into interstate commerce in violation of the Food, Drug and Cosmetic Act (FDCA).
For premium support please call: 800-290-4726 more ways to reach us